Max Healthcare and IIT Bombay ink MoU for innovation in the healthcare industry

Briefs: Dr. Reddy's Laboratories and Max Healthcare Institute

Dr. Reddy's Laboratories has been issued a Form 483 with four observations

Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007

APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery

Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare

The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova

Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in a Single test

Becomes the 1st diagnostics company in India to launch BD MAX MDR TB test

Mumbai FC Football players encourage cancer survivors at Nanavati Max Super Speciality Hospital

The players and management of Mumbai City FC presented patients with exclusive gifts, symbolizing support and appreciation for their fight against cancer

Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr

The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022

Max Healthcare Institute Q1 FY23 consolidated PAT soars at Rs. 172.83 Cr

The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.

Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX

The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.

LintonPharm to release data on Catumaxomab at ASCO meeting

The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis